Demant

At Demant we create life-changing differences through hearing health.

Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people’s hearing and health. In every aspect, from providing hearing care to delivering hearing aids and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged. The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 26,000 employees and generates annual revenue of more than DKK 22 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health. Listed on Nasdaq Copenhagen stock exchange as a blue chip stock, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Audioscan. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks. If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice

07/04/2026

Today we celebrate and join this year’s theme, “Together for health. Stand with science”, recognising the power of scientific collaboration to improve global health. As an essential part of healthcare, hearing health is also driven by this scientific approach – helping people to connect, participate and belong.

Advancing hearing health requires innovation and research, cross‑disciplinary collaboration, and a commitment to transforming evidence into life-changing differences for people living with hearing loss. And this is exactly what we bring together in our research centres to shape the future of hearing healthcare.

- Eriksholm Research Centre, the world’s leading applied hearing research facility, explores personalised audiology, cognitive hearing science, intent decoding and AI - to better understand real-life hearing needs.
- Interacoustics A/S Research Unit (IRU), based at Danmarks Tekniske Universitet - DTU, translates research into practical solutions for hearing care professionals through applied and clinical work in audiometry, electrophysiology, hearing aid fitting, and impedance.

We are proud to stand with the researchers, clinicians and collaborators who contribute to shaping a better future in hearing healthcare.

19/03/2026

[Heritage Highlights] From care to purpose

In 1902, the Demant family posed for a formal photograph - unaware that only two years later, hearing aids would become a defining part of their story and the beginning of .

At the time, Camilla Louise lived with hearing difficulties. Wanting to support her, her husband Hans Jørgen Demant travelled to London to bring home a new electric hearing aid. The change it brought to Camilla’s life spread quickly, and soon others approached him for the same help.

On 8 June 1904, he became the sole agent for General Acoustic in Denmark. This marked the start of a journey that still shapes our purpose today: improving life for people with hearing difficulties.

[This post is part of Heritage Highlights: short glimpses into the stories and materials preserved in our archives].

12/03/2026

We were pleased to welcome our shareholders to Demant’s headquarters in Smørum for our Annual General Meeting. As per tradition, the meeting is an opportunity to present the Group's development in the year that passed, including key strategic milestones such as the acquisition of KIND and the launch of hashtag .

This time, the AGM also marked an important transition for Demant’s Board of Directors. We said goodbye to Niels B. Christiansen after 18 years of dedicated service on Demant’s Board, the last nine as Chair. We are deeply grateful for his leadership and service throughout his tenure.

In his final address to Demant shareholders, Niels highlighted: “For almost two decades, I have had the pleasure of following Demant’s development closely – a journey marked by significant growth and value creation, continuous innovation and an unwavering focus on improving the lives of people with hearing loss."

Following the AGM, the Board appointed Kristian Villumsen as the new Chair. Kristian, who has been a member of Demant’s Board since 2021, brings deep insights into the healthcare industry and extensive international leadership experience from executive management and board positions.

The general assembly also elected Thomas Hofman-Bang as a new member of the Board of Directors. Thomas adds international leadership experience and a strong background in accounting and manufacturing companies. Welcome on board, Thomas!

Thank you to all shareholders for putting your trust in Demant.

03/02/2026

Today, we released our 2025 Annual Report, presenting our financial performance and sustainability progress for the past year.

▪️Key financial figures: We delivered 5% of revenue growth in local currencies, predominantly driven by good performance in our Hearing Care business area. Strategic acquisitions such as the German retailer KIND contributed meaningfully to this development.

▪️Our core impact: Demant improved over 12 million lives through innovative solutions in 2025. We also carried out 1.6 million hearing tests in our clinics, strongly contributing to raise awareness of hearing healthcare.

▪️ Innovation in focus: The launch of Oticon Zeal. The world's most discreet, complete in-ear hearing aid, marked an important milestone for the industry, setting a new standard for technology and user experience.

▪️ Climate impact: Demant reduced its scope 1 and 2 market-based GHG emissions by 9% and we met our 2025 target of sourcing 50% of the Group’s energy consumption from renewable sources.

▪️Diversity: The share of women in top‑level management increased to 33%, reflecting good progress towards our 2030 target of 35%.

👉 Explore Demant’s full 2025 financial and sustainability results in the comments.

23/12/2025

Different languages, different traditions, different teams, and different markets - all connected by one shared wish to spread joy this festive season and one shared purpose that unites us, creating life-changing differences through hearing health.

From all of us at Demant: Happy Holidays and a joyful New Year!

03/12/2025

We are thrilled to officially welcome 3,000 new colleagues to Demant and additional 650 clinics to our +4,000 clinic network, following the completion of Demant’s largest-ever acquisition: KIND.

This strategic move will allow us to help more people hear better through personalised care and innovative solutions.

Together, we will continue shaping the future of hearing healthcare.

05/11/2025

Tuesday evening, Demant published its Interim Management Statement for Q3 2025.

This quarter’s highlights include:

· The Group delivers organic growth of 3% driven by solid performance in Hearing Care
· The hearing aid market remained softer than normal with sequential slowdown in US commercial market
· Outlook for 2025: Organic growth of 1-3% and EBIT of DKK 3,900-4,300 million

Browse through our key data below.

05/11/2025

Demant released its Interim Management Statement for Q3 2025

In this video, our CEO Søren Nielsen shares his reflections on Demant’s performance in the third quarter. Among others, he highlights the Group’s 3% organic revenue growth, driven by strong results in the Hearing Care business area, and offers insights into how global macroeconomic uncertainties are impacting the hearing aid market.

Read the full statement here: https://www.demant.com/investor-relations/company-announcements #/embedded/announcement/14655735?publisherId=13560112&widget=true

22/10/2025

Redefining what’s possible: Introducing Oticon Zeal™

Today is an important day at Demant as Oticon unveils Oticon Zeal™, the world's most discreet, complete hearing aid.

With Oticon Zeal, Oticon introduces a completely new in-the-ear hearing aid category: NXT In-the-Ear, redefining what users can expect from discreet hearing solutions. For the first time, they no longer have to choose between in-the-ear discreetness and full functionality. Oticon Zeal delivers both.

This next-generation solution offers:
• Same-day fitting, a breakthrough for hearing care professionals and hearing aid users
• Advanced sound processing powered by second-generation , delivering always-on performance that adapts automatically to any environment
• Seamless connectivity, allowing hands-free calls and direct streaming. Oticon Zeal is the first hearing aid enabled for Google's Fast Pair (Google) and it also features Auracast™ technology
• Full-day battery life with convenient recharging: just 15 minutes of charging provides up to 4 hours of use
• Discreet and comfortable design

“With Oticon Zeal, we’ve created the completely new hearing aid category NXT in-the-Ear, a real gamechanger in the industry. For the first time, we’ve successfully integrated our proven technology and full functionality into a discreet in-the-ear device. This isn’t just another hearing aid: it’s a barrier-breaking solution where users don’t need to compromise on discreetness or functionality. It eliminates stigma, attracts those who’ve avoided treatment, and empowers hearing care professionals to reach more people who need help,” says Ole Asboe Jørgensen, President of Oticon Brand, Global.

Read more here: https://www.demant.com/about/latest-news/oticon-zeal

09/10/2025

Anders shows us how purpose and passion can drive both innovation and impact
👋 Meet our colleague: Anders Højsgaard Thomsen

For over 20 years, Anders, an engineer with a background in acoustics, has worked in Audiological Solutions at Hearing Aids at Demant in Denmark, most recently as a Business Owner, shaping hearing solutions through close cross-functional collaboration.

Reflecting on his journey, he shares: “I’m motivated by the opportunity to continually improve hearing solutions and see the positive impact they have on the market”. Now also serving as an employee-elected member of Demant’s Board of Directors, Anders brings both deep technical insight and the employee perspective into strategic decisions that shape our future.

Outside of work, Anders is a passionate cyclist. 🚴 Whether he's commuting to work, racing in competitions or riding with Demant’s Cycling Club, two wheels are part of his everyday life.

Thank you, Anders, for showing how passion, teamwork and purpose drive us forward.

23/09/2025

Klaus is making a difference for millions of people, and so can you.

At Demant and Oticon, we push the boundaries of innovation and break limits of what is technologically possible, all to improve the lives of those living with . From designing advanced chipsets to developing cutting-edge software and hardware, we are shaping the future of hearing healthcare, while you get to shape your career.

None of this would be possible without people like Klaus, our brilliant engineers , and one of the largest R&D departments in Denmark.

👉Want to be part of something truly life-changing?
Join Klaus and more than 1,000 dedicated specialists driving the next generation of hearing solutions.

See more here: https://lnkd.in/d7iXtXiP

&D

10/09/2025

Demant eliminates 51 tonnes of plastic from production

Sometimes, environmental sustainability improvements are to be found in the small detail.
Such as when we eliminate 51 tonnes of plastic from our production by optimising some of the accessories that come with our hearing aids. All while maintaining the same functionality and quality for the hearing aid user.

Through rethinking the production from materials to tools and working with circularity, the teams behind made results that exceeded the initial expectations.

Demant sells more than 10 million of these containers for filters, each with six handles, every year, and the redesign therefore has a significant impact on our annual plastic consumption for hearing aids production.

👉 Curious to know more? Click here: https://www.demant.com/about/latest-news/plastic-from-production

Adresse

Kongebakken 9
Smørumnedre
2765

Telefon

+4539177300

Internet side

http://www.demant.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når Demant sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til Demant:

Genveje

Vil du plassere din praksis på toppen av Klinik-listen i Smørumnedre?

Del

Type

Medicin og sundhed